Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Less is more: the human microdosing concept

R Colin Garner

    Drug Discovery Today
    |April 6, 2005
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Dose-linearity of the pharmacokinetics of an intravenous [<sup>14</sup> C]midazolam microdose in children.

    British journal of clinical pharmacology·2019
    Same author

    Evaluation of a Library of FDA-Approved Drugs for Their Ability To Potentiate Antibiotics against Multidrug-Resistant Gram-Negative Pathogens.

    Antimicrobial agents and chemotherapy·2019
    Same author

    Practical experience of using human microdosing with AMS analysis to obtain early human drug metabolism and PK data.

    Bioanalysis·2010
    Same author

    Microdose pharmacokinetics of IDX899 and IDX989, candidate HIV-1 non-nucleoside reverse transcriptase inhibitors, following oral and intravenous administration in healthy male subjects.

    Journal of clinical pharmacology·2009
    Same author

    A pharmacokinetic evaluation of five H(1) antagonists after an oral and intravenous microdose to human subjects.

    British journal of clinical pharmacology·2009
    Same author

    The utility of microdosing over the past 5 years.

    Expert opinion on drug metabolism & toxicology·2008
    Same journal

    From biologics to small-molecule modulators: The evolving landscape of interleukin-targeted therapeutics.

    Drug discovery today·2026
    Same journal

    Targeting the GLP-1 receptor pathways for dual management of obesity and depression.

    Drug discovery today·2026
    Same journal

    Chemical intervention strategies targeting MYC for cancer therapy.

    Drug discovery today·2026
    Same journal

    How many protein pairs can we chemically target?

    Drug discovery today·2026
    Same journal

    From trial-and-error to inverse design: how AI is redefining drug delivery systems.

    Drug discovery today·2026
    Same journal

    Critical evaluation of the key mediators causing life-threatening symptoms during human anaphylaxis.

    Drug discovery today·2026
    See all related articles